These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763 [TBL] [Abstract][Full Text] [Related]
3. Modulite: a simple solution to a difficult problem. Lewis DA; Ganderton D; Meakin BJ; Brambilla G Respiration; 2005; 72 Suppl 1():3-5. PubMed ID: 15915006 [TBL] [Abstract][Full Text] [Related]
5. Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations. Scichilone N; Spatafora M; Battaglia S; Arrigo R; Benfante A; Bellia V J Asthma Allergy; 2013; 6():11-21. PubMed ID: 23378776 [TBL] [Abstract][Full Text] [Related]
6. Correction to Results, Table, and Figure in: Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD. Chest; 2017 Jun; 151(6):1410. PubMed ID: 28599943 [No Abstract] [Full Text] [Related]
7. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. Berger WE; Noonan MJ J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601 [TBL] [Abstract][Full Text] [Related]
9. A review of the development of Respimat Soft Mist Inhaler. Dalby R; Spallek M; Voshaar T Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496 [TBL] [Abstract][Full Text] [Related]
10. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study. Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479 [TBL] [Abstract][Full Text] [Related]
11. Modulite technology in the development of formoterol HFA pMDI: clinical evidence and future opportunities. Bousquet J; Dell'anna C Expert Rev Respir Med; 2008 Feb; 2(1):27-36. PubMed ID: 20477219 [TBL] [Abstract][Full Text] [Related]
12. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Acerbi D; Brambilla G; Kottakis I Pulm Pharmacol Ther; 2007; 20(3):290-303. PubMed ID: 16890465 [TBL] [Abstract][Full Text] [Related]